We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

i-Sens

Develops and manufactures self monitoring blood glucose test systems, including POCT diagnostic devices such as blood... read more Featured Products: More products

Download Mobile App





i-SENS Highlights Connected Diagnostic Systems at MEDICA 2025

By LabMedica International staff writers
Posted on 17 Nov 2025

i-SENS is presenting its latest in vitro diagnostic innovations at MEDICA 2025, highlighting connected testing platforms for clinical and near-patient applications. More...

In Hall 3, Booth B51, i-SENS is showcasing its i‑SmartCare 10 and i‑Smart 30 Pro systems alongside additional point‑of‑care (POC) analyzers intended to provide precise, efficient testing across hospital laboratories and near‑patient workflows. 

The i-SmartCare 10 is a blood gas, electrolyte, and metabolites analyzer optimized for POC use. The compact and lightweight analyzer features a high-capacity battery that supports two hours of mobile, continuous testing, plus an easy-to-manage all-in-one cartridge system. The i-Smart 30 Pro is an electrolyte analyzer that measures Na+, K+, and CI- concentrations, reporting results in 35 seconds on a color screen. Added benefits include an all-in-one cartridge that can be used for four weeks, battery power for two hours, and fast and error-free data entry using a barcode scanner.

The company will also feature the CareSens Air Continuous Glucose Monitoring System (CGMS). CareSens Air CGM is a 15-day, all-in-one sensor that provides real-time glucose monitoring, with data easily accessible through the CareSens app. The sensor is just 5 mm thick and weighs only 4.5 g.. Also on display at the i-SENS booth is a wide variety of CareSens Blood Glucose Monitoring System (BGMS) models, designed for accuracy, ease of use, and reliability in diverse care environments.

i-SENS’s participation at MEDICA 2025 underscores the company’s commitment to advancing smart, connected diagnostics that enhance clinical decision-making and improve patient outcomes. By continuously developing innovative and accessible solutions, i-SENS strives to support healthcare professionals and contribute to a more connected, data-driven future of care.

Related Links:
i-SENS


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.